| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 45,065 | 45,304 | 34,489 | 53,614 | | Cost of Revenue | 17,694 | 19,606 | 13,928 | 22,879 | | | Gross Profit | 27,371 | 25,698 | 20,561 | 30,735 | | | Operating Expenses | | Research Development | 4,464 | 4,191 | 3,740 | 4,833 | | Selling General and Administrative | 14,225 | 18,360 | 15,651 | 18,699 | | Non Recurring |
-
|
-
|
-
| 22,137 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,682 | 3,147 | 1,170 | (14,934) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 530 | 3,426 | (452) | 4,747 | | Earnings Before Interest And Taxes | 9,212 | 6,573 | 718 | (10,187) | | Interest Expense | 1,041 | 1,384 | 1,872 | 347 | | Income Before Tax | 8,171 | 5,189 | (1,154) | (10,534) | | Income Tax Expense | 2,560 | 612 | (181) | 4,512 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,611 | 4,577 | (973) | (15,046) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,611 | 4,577 | (973) | (15,046) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,611 | $4,577 | ($973) | ($15,046) |
|
0.31% Nasdaq 0.00%
Income Statement
